{"SPADE_UN_13680": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2022/0125873 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2022_0125873_A1", "Patent Type": "Patent Application", "Publication Date": "2022-4-28", "Family Info": "WO2020/118427A1##CA3123101A1##BR112021011276A2##EP3897128A1##JP2022523896A##US2022/0125873A1##EP3897128A4", "Patent Title": "Antimicrobial Peptides", "Abstract": "Antimicrobial peptides (AMPs), small compounds that often exhibitbroad spectrum antimicrobial activity, are garnering interest as potential therapeutics against antibiotic-resistant bacterial pathogens. Development of new AMPs is arduous due to the practical limitations of classical protein-based discovery approaches. A high throughput bioinformatics approach is described which is able to confirm identification of known AMPs from the North American bullfrog ( Rana ( Lithobates ) catesbeiana ) genome, and a bioinformatics approach is used to develop new AMPs. The described AMPs exhibit antimicrobial activity against Mycobacterium smegmatis via microtitre broth dilution assays, indicating broader efficacy."}], "Sequence Information": {"SPADE ID": "SPADE_UN_13680", "Sequence": "SNRDFFKVNIFRLCG", "Sequence Length": 15, "Peptide Name": "Sequence 52 from Patent US 2022/0125873", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "FNR", "Absent Amino Acids": "AEHMOPQTUWY", "Basic Residues": 3, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 8, "Positive Residues": 3, "Negative Residues": 1, "Mass": 1816.09, "PI": 9.5, "Net Charge": 2, "Hydrophobicity": -0.08, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13681", "Similarity": 0.8666666666666667, "Sequence": "SNRKFFKVRIFRLCG"}, {"SPADE_ID": "SPADE_UN_13692", "Similarity": 0.8666666666666667, "Sequence": "SNRDFFMVNIFGLCGPFGIMERKRR"}, {"SPADE_ID": "SPADE_UN_17630", "Similarity": 0.8333333333333334, "Sequence": "RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ"}]}}}